Targeted activation of Nrf2 inhibits ROS production, thereby suppressing the proliferation and migration of fibroblast-like synovial cells, which resemble fibroblasts in rheumatoid arthritis [156]. Here, NFE2L2 is linked to rheumatoid arthritis.